Share

FDA Approves Semaglutide Injection For the Treatment of Adults with Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) approved semaglutidea once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The drug, produced by Novo Nordisk and marketed as OZEMPIC®, is administered once weekly, on the same day each week, and can be taken...
Share

Clinical Features and Outcomes in Children with Adrenocortical Tumors without Germline TP53 Mutations Described

Researchers have described clinical features and outcomes in children with adrenocortical tumors (ACTs) without germline TP53 mutations, according to a study recently published in the Journal of Clinical Oncology. Emilia Modolo Pinto, PhD, Raul C. Ribeiro, MD, and colleagues of St. Jude Children’s Research Hospital in Memphis, Tenn., point out that ACTs are cancers caused...
Share

Case of the Month: ESAP Special Edition

esap cover This issue highlights a special edition of ESAP, available for a limited time. Test your clinical knowledge with this free case to discover the rich intellectual legacy of endocrinology. Available on the online store. Clinical Vignette A 62-year-old man is referred for assistance in the management of hyperprolactinemia and diminished libido. Over the past 9...
Share

High Blood Pressure During Pregnancy Linked to Increased Risk of Offspring Obesity

When expectant mothers have elevated blood pressure during pregnancy, it may raise their children’s risk of developing childhood obesity, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. “Our study is the first to demonstrate that among pregnant women, elevated blood pressure is associated with a greater risk of overweight...
Share

Highs & Lows: Reevaluating Hypoglycemia in Elderly Diabetes Patients

EN1117_cover Hypoglycemia, a misunderstood diabetes complication, not only confounds the public and patients, but many healthcare providers as well. Elderly diabetes patients with hypoglycemia are especially vulnerable to this dilemma. Mary M. Julius, RDN, CDE, clinical coordinator of Diabetes Self Management Education and Support and a research dietician and nutritionist at the Department of Veteran’s Affairs...
Show More

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.